A new study by Israeli researchers suggests that sildenafil, the active ingredient in Viagra, may help inhibit the spread of cancer cells in certain types of tumors.
The research, published on August 4, 2026, indicates that the drug could potentially be used alongside traditional chemotherapy to improve patient outcomes and reduce metastasis.
While the findings are promising, scientists emphasize that further clinical trials are required to determine the appropriate dosage and safety profile for cancer patients before it can be prescribed.